Global Impact from the U.S. to Korea at FAVA 2024

We are excited to share that Dr. Lucas Rodrigues, FidoCure's Head of Veterinary Research, will be presenting twice at the 23rd Federation of Asian Veterinary Associations (FAVA) Congress, taking place from October 25 to October 27, 2024. This event marks an important opportunity for us to engage with veterinary professionals from around the world and contribute to the ongoing dialogue about canine cancer treatment.

FidoCure’s research at FAVA 2024 reflects the increasing global recognition of our research in veterinary oncology. This congress provides us with a platform to share our insights and AI-driven practices with veterinarians from across Asia and beyond. By doing so, we aim to foster collaboration and expand our impact, ultimately benefiting more dogs and their families facing the challenges of cancer.

Presentations by Dr. Lucas Rodrigues

Dr. Rodrigues will deliver two informative presentations that highlight FidoCure’s role in precision veterinary medicine.

In his first presentation, titled "Decoding Canine Cancer: Exploring Genetic Alterations and Their Impact on Treatment," Dr. Rodrigues will delve into the genetic underpinnings of canine cancer. He will discuss how our understanding of genetic alterations is shaping treatment strategies and explore the lessons learned from precision medicine in human oncology. Key topics will include the importance of genetic testing for informed decision-making and the role of next-generation sequencing in enhancing veterinary oncology. Dr. Rodrigues will also cover the development of targeted therapies based on genetic profiles and the significance of genetic biomarkers in predicting treatment outcomes.

The second presentation, "Implementing Small Molecules for Targeted Therapy in Canine Cancer," will provide practical guidance for veterinary professionals looking to integrate targeted therapies into their practice. Dr. Rodrigues will review several small molecules relevant to canine cancer treatment. He will explain how these therapies work by targeting specific molecular pathways and share real-world applications, practices, and protocols for their implementation in clinical settings. Additionally, Dr. Rodrigues will discuss emerging trends and ongoing research in the field of small-molecule targeted therapy.

Advancing Global Canine Cancer Care

FidoCure’s involvement at FAVA 2024 demonstrates our commitment to enhancing veterinary oncology on a global scale. By sharing our research and practical experiences with a diverse audience, we hope to contribute to the development of more effective and tailored cancer treatments for dogs everywhere. Additionally, this recognition from the international veterinary community strengthens our resolve to continue our research and development efforts. As we broaden our global outreach, we remain focused on improving the quality of life for dogs battling cancer and supporting the families around the world who care for them.